Reports for BIOMED PHARMA

Company Name

BIOMED PHARMA

Totals

Shortage reports

134

Actual shortage: 62 (46%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 72 (54%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

17 (13%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BIO-EZETIMIBE 10MG TABLET Resolved 2020-01-22 2020-02-07 103954
BIO-ROSUVASTATIN 5MG TABLET Resolved 2020-06-15 2022-01-31 117695
BIO-ROSUVASTATIN 10MG TABLET Resolved 2020-06-15 2022-01-31 117698
BIO-ROSUVASTATIN 20MG TABLET Resolved 2020-06-15 2022-01-31 117701
BIO-MOXIFLOXACIN 400MG TABLET Actual shortage 2020-11-05 2020-12-01 127818
BIO-GABAPENTIN 100MG CAPSULE Actual shortage 2020-11-05 2020-11-06 127822
BIO-GABAPENTIN 300MG CAPSULE Actual shortage 2020-11-05 2020-11-05 127825
BIO-GABAPENTIN 400MG CAPSULE Actual shortage 2020-11-05 2020-11-06 127830
BIO-LEVETIRACETAM 500MG TABLET Actual shortage 2021-01-13 2021-01-13 131506
BIO-QUETIAPINE 200MG TABLET Actual shortage 2021-01-13 2021-01-13 131509
BIO-ROSUVASTATIN 40MG TABLET Resolved 2021-01-13 2022-01-31 131512
BIO-GABAPENTIN 800MG TABLET Actual shortage 2021-04-06 2021-05-31 136939
BIO-AMLODIPINE 5MG TABLET Resolved 2021-10-14 2021-10-26 147158
BIO-ANASTROZOLE 1MG TABLET Resolved 2021-10-14 2021-10-26 147165

Showing 121 to 134 of 134

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0